RAPP Competitors & Alternatives
Compare Rapport Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
RAPP
Main Stock$37.07
Tradestie Score
58
Market Cap
$1.32B
Analyst Upside
+47.6%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$32.68
|
$1.97B | - | 54 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.16
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$137.68
|
$1.92B | - | 60 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$56.93
|
$1.90B | 348.8 | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$37.32
|
$1.84B | - | 55 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.05
|
$1.81B | - | 50 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$4.09
|
$1.78B | - | 47 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.29
|
$1.78B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.82
|
$1.74B | - | 59 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$31.34
|
$1.68B | - | 54 | Compare |
More RAPP Analysis
Data updated: May 15, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry